FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia.
Current medicinal chemistry
View this publicationCurrent medicinal chemistry
View this publicationCell reports
View this publicationThe European respiratory journal
View this publicationTranslational psychiatry
View this publicationEuropean radiology experimental
View this publicationiScience
View this publicationInternational journal of molecular sciences
View this publicationAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
View this publicationiScience
View this publicationJournal of psychiatric research
View this publication